(Dave Bedard photo)

New study on glyphosate to feed into crucial EU vote

London | Reuters — Results of a new animal study into possible health risks of glyphosate will be published in time to inform a key EU re-licensing vote due by the end of 2017, according to the researcher leading the trial. A row over possible effects of glyphosate — an ingredient in Monsanto’s herbicide Roundup […] Read more



(Dave Bedard photo)

EU chemical agency says glyphosate not carcinogenic

Helsinki | Reuters — Glyphosate, the key ingredient in Monsanto’s Roundup herbicide, should not be classified as a substance causing cancer, the European Chemical Agency concluded on Wednesday, potentially paving the way for its licence renewal in the EU. A transatlantic row over possible risks to human health has prompted investigations by congressional committees in […] Read more

(Dave Bedard photo)

Monsanto ghostwrote Roundup studies, plaintiffs in U.S. suit say

Reuters — Employees of Monsanto ghostwrote scientific reports that U.S. regulators relied on to determine that a chemical in its Roundup herbicide does not cause cancer, farmers and others suing the company claimed in court filings. The documents, made public Tuesday, are part of a mass litigation in federal court in San Francisco claiming Monsanto […] Read more


(Dave Bedard photo)

Bayer, Monsanto start asset sale toward merger clearance

Frankfurt | Reuters — German drug and crop chemical maker Bayer and U.S. seeds company Monsanto are launching asset sales worth roughly US$2.5 billion as they seek regulatory clearance for their US$66 billion merger, people close to the matter said. To kick off an auction process, Bayer’s advisors will send out information packages next week […] Read more



(Bayer.com)

Bayer, Monsanto confirm spending plans after meeting Trump

Frankfurt | Reuters –– Bayer and Monsanto said Tuesday they would spend at least half of their agriculture research and development budget in the U.S. over the next six years, following a meeting with U.S. president-elect Donald Trump last week. The two companies, which are awaiting approval of their agreed US$66 billion deal from Trump’s […] Read more

(Dave Bedard photo)

Monsanto swings to profit on South American demand

Chicago | Reuters — U.S. seeds and agrochemicals company Monsanto, in the process of being bought by Germany’s Bayer for US$66 billion, swung to a quarterly profit, helped by higher demand from South America. Sales of soybe2an seeds and traits jumped 37 per cent as more farmers in South America sowed the company’s genetically modified […] Read more



(Dave Bedard photo)

Monsanto shareholders back Bayer deal

Chicago | Reuters –– Shareholders of U.S. seeds and agrochemicals company Monsanto approved the company’s US$66 billion acquisition by Bayer on Tuesday, a deal that still requires regulatory approval to close as expected in late 2017. Increased research and development spending by the combined companies and plans to develop a global seeds and biotechnology hub […] Read more